
ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential
Researchers in the United States have shown the inhalation of an angiotensin-converting enzyme 2 (ACE2) decoy receptor, sACE22.v2.4-IgG1, increases survival and ameliorates lung injury in...